Cargando…
Pancreatic cancer microenvironment, to target or not to target?
We have collectively been spoiled by the astounding clinical benefit of antimicrobials. Much like the discovery and use of penicillin to eradicate once deadly infections, we continue to desperately search for the next “magic bullet” to kill cancer while sparing the non‐transformed cells. Greater app...
Autores principales: | Carr, Ryan M, Fernandez‐Zapico, Martin E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734844/ https://www.ncbi.nlm.nih.gov/pubmed/26747091 http://dx.doi.org/10.15252/emmm.201505948 |
Ejemplares similares
-
Targeting tumour microenvironment, a FAKtual challenge in pancreatic cancer
por: Tolosa, Ezequiel J, et al.
Publicado: (2020) -
Toward personalized TGFβ inhibition for pancreatic cancer
por: Carr, Ryan M, et al.
Publicado: (2019) -
PI3Kα targeting, nipping pancreatic cancer evolution in the bud
por: Raja Arul, Glancis Luzeena, et al.
Publicado: (2021) -
Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?
por: Paradise, Brooke D., et al.
Publicado: (2018) -
Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
por: Gillson, Josef, et al.
Publicado: (2020)